Non-invasive preimplantation cumulus cell test (Aurora niPCT) that analyzes cumulus cells to identify the highest-quality oocyte for prioritized embryo transfer, improving first-transfer live-birth rates. Targets IVF clinics and couples, aiming to increase pregnancy on the first attempt and reduce overall treatment burden.